RMD
ResMed Inc
222.00$
+0.0%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +5.5% | +2.9% | +2.2% | +0.1% | +4.7% | +0.8% | +4.4% | -0.9% | +6.5% | +0.6% | +2.3% | – | |
| – | -1.8% | +4.5% | +0.7% | -2.2% | +4.6% | -1.0% | +0.5% | -2.5% | +4.5% | +0.4% | +11.5% | – | |
| – | +11.6% | +1.8% | +3.3% | +1.8% | +4.7% | +2.0% | +7.0% | +0.1% | +7.8% | +0.7% | -3.3% | – | |
| – | -2.4% | +4.3% | +4.9% | -1.7% | +2.3% | +3.2% | +3.0% | +1.0% | +4.2% | +3.6% | +12.2% | – | |
| – | -0.3% | +3.5% | +5.3% | -1.3% | +1.1% | +1.5% | +8.1% | -2.2% | +7.4% | +2.6% | +3.7% | – | |
| – | +26.8% | -22.1% | +5.2% | +2.1% | +1.3% | +1.8% | +7.5% | +2.4% | +3.4% | +1.1% | +5.5% | – | |
| – | -4.8% | +36.2% | +1.8% | +1.6% | +7.7% | +2.2% | +6.6% | -1.8% | +11.4% | +0.4% | -10.2% | – | |
| – | -7.7% | +4.1% | -33.6% | -42.4% | -13.0% | -33.5% | +80.9% | +52.7% | -9.6% | +54.6% | +70.0% | – | |
| – | -4.7% | +44.7% | -4.7% | +7.2% | +9.1% | -0.2% | +9.7% | -2.5% | +11.0% | +1.2% | -5.6% | – | |
| – | -4.0% | +47.9% | -12.6% | +10.1% | +2.2% | -28.6% | +48.8% | +25.4% | +5.4% | +0.0% | -12.4% | – | |
| – | -4.8% | +43.9% | -2.7% | +6.5% | +10.7% | +5.9% | +4.0% | -8.2% | +12.6% | +1.6% | -3.8% | – | |
| – | +10.7% | +17.8% | -18.5% | +22.2% | +8.2% | -2.0% | +13.4% | -5.5% | +12.5% | +3.0% | -15.5% | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.